Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-04 Sale |
2025-02-06 8:27 pm |
RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer |
3,770 | $21.38 | $80,615 | 57,235 (Direct) |
View |
| 2024-02-02 Sale |
2024-02-06 8:18 pm |
RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer |
12,628 | $1.1354 | $14,338 | 402,891 (Direct) |
View |
| 2023-02-02 Sale |
2023-02-06 5:40 pm |
RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer |
5,389 | $1.6601 | $8,946 | 196,519 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-17 Option Award |
2025-03-19 8:56 pm |
N/A 2031-01-27 |
RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer |
13,475 | $0 | 13,475 (Direct) |
View |
| 2025-01-29 Option Award |
2025-01-31 6:47 pm |
N/A 2035-01-29 |
RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer |
34,505 | $0 | 75,793 (Direct) |
View |
| 2024-11-25 Option Award |
2024-11-26 8:01 pm |
N/A 2033-01-26 |
RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer |
6,250 | $0 | 6,250 (Direct) |
View |
| 2024-08-30 Option Award |
2024-09-04 8:33 pm |
N/A 2030-02-06 |
RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer |
10,000 | $0 | 10,000 (Direct) |
View |
| 2024-02-28 Option Award |
2024-03-01 7:16 pm |
N/A 2033-01-26 |
RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer |
141,000 | $0 | 141,000 (Direct) |
View |
| 2024-01-23 Option Award |
2024-01-25 9:16 pm |
N/A 2034-01-23 |
RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer |
366,000 | $0 | 572,519 (Direct) |
View |
| 2023-01-26 Option Award |
2023-01-30 9:45 pm |
N/A 2032-01-24 |
RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer |
238,000 | $0 | 426,908 (Direct) |
View |
| 2022-12-28 Option Award |
2022-12-30 4:30 pm |
N/A 2032-01-24 |
RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-09-14 Option Award |
2022-09-16 4:15 pm |
N/A 2029-01-23 |
RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer |
81,250 | $0 | 81,250 (Direct) |
View |
| 2022-01-24 Option Award |
2022-01-26 8:47 pm |
N/A 2032-01-24 |
RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP &Chief Financial Officer |
150,000 | $0 | 228,908 (Direct) |
View |
| 2021-11-04 Option Award |
2021-11-05 7:06 pm |
N/A 2029-01-23 |
RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer |
81,250 | $0 | 81,250 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-02 6:23 pm |
N/A 2030-02-06 |
RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP &Chief Financial Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2021-01-27 Option Award |
2021-01-29 6:55 pm |
N/A 2031-01-27 |
RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP &Chief Financial Officer |
112,500 | $0 | 112,500 (Direct) |
View |